Prevention is possible, especially for Rh incompatibility. Administering RhIg to Rh-negative mothers during and after pregnancy can significantly reduce the risk of developing antibodies against Rh-positive fetal cells. Regular prenatal care and early blood tests can also help in early detection and management.
